Johnson & Johnson generated $92.1B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $25.1B with a 27.26% net margin. Diluted EPS is $10.36, which grew 0.7% year-over-year. Based on the Q3 2025 filing.
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 |
|---|---|---|---|---|---|---|
| Gross profit | 0.69 | 0.69 | 61349999997.92 | 0.66 | 0.68 | 0.70 |
We use cookies for analytics. See our Privacy and Cookie Policy.